Real Regulatory to Attend the Good Clinical Practice Symposium 2020
Will you be at the Good Clinical Practice Symposium 2020 in London?
In partnership with the US Food and Drug Administration (FDA), this event will provide regulatory perspectives on the importance of sponsor oversight of the running of clinical trials, protocol deviations including the impact on clinical trials, and the challenges in ensuring data quality in novel clinical trial designs.
Chat with our team about how we can help you with controlling, managing and tracking clinical trial submissions on your behalf and thereby providing the tangible evidence of the trial oversight for future inspections.
To arrange a meeting at a time convenient to you, contact us today. We look forward to seeing you there!
Attendees: Dorothee Fouchier
Dorothée joined the company in May 2006 and has worked in regulatory affairs since 2003 mainly in human medicinal product, including small chemical entity and biotechnology products. Previously Dorothée was part of the CMC regulatory team at the manufacturing site of a major pharmaceutical company.
Dorothée’s current role is as Managing Consultant of the Irish office.
As part of the management team Dorothee has managed projects through the full product lifecycle from early development to product maintenance and MAH compliance. She has also supported several clients in preparation of inspection readiness. Dorothée oversees and manages our Irish office whilst providing expert consultancy to her client projects.